See the DrugPatentWatch profile for ozempic

Ozempic, a prescription medication used to improve blood sugar control in adults with type 2 diabetes, is typically injected subcutaneously once a week [1]. This injection frequency is based on the drug's active ingredient, semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist [1].

It is important to note that the injection frequency may vary depending on the specific dosage prescribed by a healthcare professional. Therefore, it is crucial to follow the dosing instructions provided by a healthcare provider or pharmacist [1].

In terms of administration, Ozempic is typically injected into the thigh, abdomen, or upper arm [1]. The injection site should be rotated to minimize the risk of injection site reactions [1].

In conclusion, the typical injection frequency for Ozempic is once a week, but it is essential to follow the specific dosing instructions provided by a healthcare professional.

Sources:
[1] DrugPatentWatch.com. (n.d.). Ozempic. Retrieved from <https://www.drugpatentwatch.com/drugs/ozempic>.